Abstract
CLINICAL QUESTION: Should patients with preoperative atrial fibrillation who are undergoing cardiac surgery undergo concomitant atrial fibrillation surgery? BOTTOM LINE: There is moderate-quality evidence that concomitant atrial fibrillation surgery approximately doubles the likelihood of freedom from atrial fibrillation, atrial flutter, or atrial tachycardia while not receiving antiarrhythmic medications at least 3 months after the procedure with a small absolute increase in needing a permanent pacemaker.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 334-335 |
| Number of pages | 2 |
| Journal | JAMA Cardiology |
| Volume | 2 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 1 2017 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
}
Concomitant atrial fibrillation surgery for people undergoing cardiac surgery. / Huffman, Mark Daniel; Malaisrie, S Chris; Karmali, Kunal N.
In: JAMA Cardiology, Vol. 2, No. 3, 01.03.2017, p. 334-335.Research output: Contribution to journal › Article
TY - JOUR
T1 - Concomitant atrial fibrillation surgery for people undergoing cardiac surgery
AU - Huffman, Mark Daniel
AU - Malaisrie, S Chris
AU - Karmali, Kunal N.
PY - 2017/3/1
Y1 - 2017/3/1
N2 - CLINICAL QUESTION: Should patients with preoperative atrial fibrillation who are undergoing cardiac surgery undergo concomitant atrial fibrillation surgery? BOTTOM LINE: There is moderate-quality evidence that concomitant atrial fibrillation surgery approximately doubles the likelihood of freedom from atrial fibrillation, atrial flutter, or atrial tachycardia while not receiving antiarrhythmic medications at least 3 months after the procedure with a small absolute increase in needing a permanent pacemaker.
AB - CLINICAL QUESTION: Should patients with preoperative atrial fibrillation who are undergoing cardiac surgery undergo concomitant atrial fibrillation surgery? BOTTOM LINE: There is moderate-quality evidence that concomitant atrial fibrillation surgery approximately doubles the likelihood of freedom from atrial fibrillation, atrial flutter, or atrial tachycardia while not receiving antiarrhythmic medications at least 3 months after the procedure with a small absolute increase in needing a permanent pacemaker.
UR - http://www.scopus.com/inward/record.url?scp=85031413171&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85031413171&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2016.5404
DO - 10.1001/jamacardio.2016.5404
M3 - Article
C2 - 28196179
AN - SCOPUS:85031413171
VL - 2
SP - 334
EP - 335
JO - JAMA Cardiology
JF - JAMA Cardiology
SN - 2380-6583
IS - 3
ER -